Gray Kueberuwa
Company: InstilBio UK
Job title: Senior Director, Development
Seminars:
ITIL-306; TILs Modified with a Co-Stimulatory Antigen Receptor (CoStAR) Targeting FOLR1 3:15 pm
CoStAR enhances T-cell effector function and proliferation in an IL-2 independent manner CoStAR is not prone to on-target, off-tumour toxicity experienced with CARs Currently being evaluated in a phase 1a/1b clinical trial evaluating safety and feasibility; TIL-306-201 Read more
day: Day 2 - Track B - PM